Terms: = Endocrine gland cancer AND KMT2D, ENSG00000167548, 8085, MLL2 AND Prognosis
18 results:
1. Successful immunotherapy with PD-1 Iinhibitor for advanced pancreatic cancer: report of two cases and review of literature.
Qiu L; Liu C; Li H
Anticancer Drugs; 2024 Mar; 35(3):263-270. PubMed ID: 38194502
[TBL] [Abstract] [Full Text] [Related]
2. [Clinicopathologic characteristics and prognostic analysis of testicular diffuse large B-cell lymphoma].
Wang Y; Shi ZY; Shi Q; Wang S; Zhang MC; Shen R; He Y; Qiu HL; Yi HM; Dong L; Wang L; Cheng S; Xu PP; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):321-327. PubMed ID: 37357002
[No Abstract] [Full Text] [Related]
3. Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine Tumors and Metastases.
Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
[TBL] [Abstract] [Full Text] [Related]
4. Coincidence of primary adrenocortical carcinoma and melanoma: three CASE reports.
Ko YL; Kumar V; Lippert J; Diaz-Cano S; Skordilis K; Kimpel O; Kircher S; Asia M; Elhassan YS; Altieri B; Ronchi CL
BMC Endocr Disord; 2023 Jan; 23(1):4. PubMed ID: 36604647
[TBL] [Abstract] [Full Text] [Related]
5. Treatment landscape of metastatic pancreatic cancer.
De Dosso S; Siebenhüner AR; Winder T; Meisel A; Fritsch R; Astaras C; Szturz P; Borner M
Cancer Treat Rev; 2021 May; 96():102180. PubMed ID: 33812339
[TBL] [Abstract] [Full Text] [Related]
6. Identification of germline and somatic mutations in pancreatic adenosquamous carcinoma using whole exome sequencing.
Ma H; Song B; Guo S; Li G; Jin G
Cancer Biomark; 2020; 27(3):389-397. PubMed ID: 31958074
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of Pancreatic cancer Patients Receiving Neoadjuvant Treatment.
Yoon KA; Woo SM; Kim YH; Kong SY; Lee MK; Han SS; Kim TH; Lee WJ; Park SJ
Gut Liver; 2019 Nov; 13(6):683-689. PubMed ID: 30970447
[TBL] [Abstract] [Full Text] [Related]
8. Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming.
Koutsioumpa M; Hatziapostolou M; Polytarchou C; Tolosa EJ; Almada LL; Mahurkar-Joshi S; Williams J; Tirado-Rodriguez AB; Huerta-Yepez S; Karavias D; Kourea H; Poultsides GA; Struhl K; Dawson DW; Donahue TR; Fernández-Zapico ME; Iliopoulos D
Gut; 2019 Jul; 68(7):1271-1286. PubMed ID: 30337373
[TBL] [Abstract] [Full Text] [Related]
9. The Use of Biomarkers in Early Diagnostics of Pancreatic cancer.
Kunovsky L; Tesarikova P; Kala Z; Kroupa R; Kysela P; Dolina J; Trna J
Can J Gastroenterol Hepatol; 2018; 2018():5389820. PubMed ID: 30186820
[TBL] [Abstract] [Full Text] [Related]
10. Clinical and genetic determinants of ovarian metastases from colorectal cancer.
Ganesh K; Shah RH; Vakiani E; Nash GM; Skottowe HP; Yaeger R; Cercek A; Lincoln A; Tran C; Segal NH; Reidy DL; Varghese A; Epstein AS; Sonoda Y; Chi D; Guillem J; Temple L; Paty P; Hechtman J; Shia J; Weiser M; Aguilar JG; Kemeny N; Berger MF; Saltz L; Stadler ZK
Cancer; 2017 Apr; 123(7):1134-1143. PubMed ID: 27875625
[TBL] [Abstract] [Full Text] [Related]
11. Reduced Expression of Histone Methyltransferases KMT2C and kmt2d Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma.
Dawkins JB; Wang J; Maniati E; Heward JA; Koniali L; Kocher HM; Martin SA; Chelala C; Balkwill FR; Fitzgibbon J; Grose RP
Cancer Res; 2016 Aug; 76(16):4861-71. PubMed ID: 27280393
[TBL] [Abstract] [Full Text] [Related]
12. Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in a BRAF(V600E) Mutation-Prevalent Area.
Jeon MJ; Chun SM; Kim D; Kwon H; Jang EK; Kim TY; Kim WB; Shong YK; Jang SJ; Song DE; Kim WG
Thyroid; 2016 May; 26(5):683-90. PubMed ID: 26980298
[TBL] [Abstract] [Full Text] [Related]
13. Follicular cell-derived thyroid cancer.
Dralle H; Machens A; Basa J; Fatourechi V; Franceschi S; Hay ID; Nikiforov YE; Pacini F; Pasieka JL; Sherman SI
Nat Rev Dis Primers; 2015 Dec; 1():15077. PubMed ID: 27188261
[TBL] [Abstract] [Full Text] [Related]
14. Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature.
Ghatnekar O; Andersson R; Svensson M; Persson U; Ringdahl U; Zeilon P; Borrebaeck CA
Int J Cancer; 2013 Nov; 133(10):2392-7. PubMed ID: 23649606
[TBL] [Abstract] [Full Text] [Related]
15. [Interdisciplinary cooperation in the treatment of complex patients with advanced testicular germ cell tumor].
Heidenreich A; Krege S; Flasshove M
Urologe A; 2004 Dec; 43(12):1521-30. PubMed ID: 15592709
[TBL] [Abstract] [Full Text] [Related]
16. [prognosis in pancreatic carcinoma].
Friess H; Isenmann R; Berberat P; Kleeff J; Büchler MW
Ther Umsch; 1996 May; 53(5):401-7. PubMed ID: 8685859
[TBL] [Abstract] [Full Text] [Related]
17. [Results of fertility preserving operations in malignant ovarian tumors].
Kleine W
Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006
[TBL] [Abstract] [Full Text] [Related]
18. [Tumor of the pancreas. Support treatment].
Da Silva Mde L
Arq Gastroenterol; 1994; 31(3):111-8. PubMed ID: 7538290
[TBL] [Abstract] [Full Text] [Related]
